# TOX2

## Overview
TOX2 is a gene that encodes the TOX high mobility group box family member 2, a transcription factor involved in the regulation of immune cell differentiation and function. This protein is primarily expressed in T follicular helper (T FH) cells, where it plays a crucial role in maintaining their identity and function by regulating the expression of key genes associated with T FH cell phenotype, such as PDCD1, BCL6, and IL21 (Horiuchi2021Tox2). TOX2 functions in the nucleus, where it modulates chromatin accessibility and gene expression, often in cooperation with other transcription factors like Bcl6 (Xu2019The). Beyond its role in normal immune function, TOX2 is implicated in oncogenesis, particularly in natural killer/T cell lymphoma (NKTL), where its expression is driven by super-enhancers and is associated with poor clinical outcomes (Zhou2023Superenhancerdriven). The regulatory mechanisms and interactions of TOX2 underscore its significance in both immune regulation and cancer biology.

## Function
The TOX2 gene encodes a transcription factor that plays a critical role in the development and function of T follicular helper (T FH) cells, a specialized subset of CD4+ T cells. TOX2 is highly expressed in germinal center (GC) T FH cells, where it is crucial for maintaining their identity and function. It prevents the conversion of T FH cells into T H 1-like cells by maintaining the expression of T FH-associated genes such as PDCD1, BCL6, and IL21 (Horiuchi2021Tox2). 

TOX2 works in conjunction with Bcl6, a key transcription factor in T FH cell development, to regulate chromatin accessibility and gene expression, promoting the T FH cell phenotype (Xu2019The). This cooperation is essential for the expression of T FH markers like CXCR5 and PD1, which are important for the cells' function in the immune response (Horiuchi2021Tox2). 

In human cells, TOX2 is primarily active in the nucleus, where it binds to DNA to modulate transcription, impacting cellular differentiation and immune homeostasis (Xu2019The). Its activity is crucial for the generation of memory T FH cells and the maintenance of durable GC T FH cell responses, which are vital for effective antibody production and adaptive immunity (Horiuchi2021Tox2).

## Clinical Significance
TOX2 (TOX high mobility group box family member 2) is implicated in the pathogenesis of natural killer/T cell lymphoma (NKTL), an aggressive form of non-Hodgkin lymphoma. The gene is overexpressed in NKTL, driven by super-enhancers, and its high expression is associated with poor survival outcomes in patients. This overexpression promotes NKTL cell growth, proliferation, and colony formation, while its knockdown results in decreased cell growth and increased apoptosis, indicating its role in oncogenesis (Zhou2023Superenhancerdriven). The transcription factor RUNX3 binds to the super-enhancer region of TOX2, enhancing its transcription, and is also overexpressed in NKTL, suggesting a regulatory pathway that contributes to the malignancy (Zhou2023Superenhancerdriven).

TOX2 is also involved in the regulation of the metastatic oncogene PTP4A3 (PRL-3), which is crucial for TOX2-mediated oncogenesis in NKTL. The knockdown of TOX2 leads to the downregulation of PRL-3 and other genes associated with cancer progression, suggesting that TOX2's interaction with these genes plays a significant role in NKTL development and therapy resistance (Zhou2023Superenhancerdriven). These findings highlight TOX2 as a potential therapeutic target in NKTL.

## Interactions
TOX2 interacts with several proteins and nucleic acids, forming complexes that play significant roles in transcriptional regulation. In the context of T-cell acute lymphoblastic leukemia (T-ALL), TOX2 forms a nuclear complex with TOX, which represses the transcriptional activity of the HAVCR2 promoter, linked to TIM3 expression. This complex recruits transcriptional co-repressors such as LCOR and HDAC3 to mediate its repressive effects (Li2024TOX2). The nuclear translocation of TOX2 is regulated by the deacetylase Sirt1 and the kinase TBK1, which influence TOX2's acetylation status and nuclear export (Li2024TOX2).

In natural killer/T cell lymphoma (NKTL), TOX2 expression is driven by a super-enhancer, with RUNX3 binding to this region to activate TOX2 transcription. RUNX3's interaction with the super-enhancer region is crucial for TOX2 expression, and knockdown of RUNX3 results in decreased TOX2 levels (Zhou2023Superenhancerdriven). Additionally, TOX2 is involved in a gene-gene interaction network, with PRL-3 identified as a key downstream oncogene regulated by TOX2 (Zhou2023Superenhancerdriven). These interactions highlight TOX2's role in oncogenesis and transcriptional regulation through its complex formation and regulatory mechanisms.


## References


[1. (Li2024TOX2) Anzhou Li, Junbao Zhang, Liangping Zhan, Xiufeng Liu, Xiliang Zeng, Qian Zhu, Zifeng Wang, and Jiang Li. Tox2 nuclear-cytosol translocation is linked to leukemogenesis of acute t-cell leukemia by repressing tim3 transcription. Cell Death &amp; Differentiation, July 2024. URL: http://dx.doi.org/10.1038/s41418-024-01352-z, doi:10.1038/s41418-024-01352-z. This article has 0 citations.](https://doi.org/10.1038/s41418-024-01352-z)

[2. (Xu2019The) Wei Xu, Xiaohong Zhao, Xiaoshuang Wang, Han Feng, Mengting Gou, Wei Jin, Xiaohu Wang, Xindong Liu, and Chen Dong. The transcription factor tox2 drives t follicular helper cell development via regulating chromatin accessibility. Immunity, 51(5):826-839.e5, November 2019. URL: http://dx.doi.org/10.1016/j.immuni.2019.10.006, doi:10.1016/j.immuni.2019.10.006. This article has 106 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2019.10.006)

[3. (Zhou2023Superenhancerdriven) Jianbiao Zhou, Sabrina Hui-Min Toh, Tze King Tan, Kalpnaa Balan, Jing Quan Lim, Tuan Zea Tan, Sinan Xiong, Yunlu Jia, Siok-Bian Ng, Yanfen Peng, Anand D. Jeyasekharan, Shuangyi Fan, Soon Thye Lim, Chin-Ann Johnny Ong, Choon Kiat Ong, Takaomi Sanda, and Wee-Joo Chng. Super-enhancer-driven tox2 mediates oncogenesis in natural killer/t cell lymphoma. Molecular Cancer, April 2023. URL: http://dx.doi.org/10.1186/s12943-023-01767-1, doi:10.1186/s12943-023-01767-1. This article has 14 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s12943-023-01767-1)

[4. (Horiuchi2021Tox2) Shu Horiuchi, Hanchih Wu, Wen-Chun Liu, Nathalie Schmitt, Jonathan Provot, Yang Liu, Salah-Eddine Bentebibel, Randy A. Albrecht, Michael Schotsaert, Christian V. Forst, Bin Zhang, and Hideki Ueno. Tox2 is required for the maintenance of gc t fh cells and the generation of memory t fh cells. Science Advances, October 2021. URL: http://dx.doi.org/10.1126/sciadv.abj1249, doi:10.1126/sciadv.abj1249. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciadv.abj1249)